rotenone has been researched along with Movement Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Ge, X; Huang, W; Shao, Q; Xu, Z; Yang, Y; Zhang, X | 1 |
| Abdelrahman, A; Ahmed, OG; Mahmoud, ME; Monir, DM; Rehan, IF | 1 |
| Colwell, KL; Gidyk, DC; Klein, A; Metz, GA; Shriner, AM; Tatton, NA; Tatton, WG | 1 |
| Champy, P; Féger, J; Hirsch, EC; Höglinger, GU; Michel, PP; Oertel, WH; Parain, K; Prigent, A; Ruberg, M | 1 |
4 other study(ies) available for rotenone and Movement Disorders
| Article | Year |
|---|---|
Drp1, a potential therapeutic target for Parkinson's disease, is involved in olfactory bulb pathological alteration in the Rotenone-induced rat model.
Topics: Animals; Dynamins; Inflammasomes; Male; Mitochondria; Movement Disorders; Neurons; NF-kappa B; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Olfactory Bulb; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotenone; Smell; Tyrosine 3-Monooxygenase; Uncoupling Agents | 2020 |
Forced exercise activates the NrF2 pathway in the striatum and ameliorates motor and behavioral manifestations of Parkinson's disease in rotenone-treated rats.
Topics: Animals; Antiparkinson Agents; Behavior, Animal; Gait Disorders, Neurologic; Levodopa; Male; Memory, Short-Term; Movement Disorders; Neostriatum; NF-E2-Related Factor 2; Parkinson Disease, Secondary; Physical Conditioning, Animal; Psychomotor Performance; Rats; Rats, Wistar; Rotenone; Signal Transduction; Tyrosine 3-Monooxygenase; Uncoupling Agents; Up-Regulation | 2020 |
Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.
Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Functional Laterality; Insecticides; Medial Forebrain Bundle; Movement; Movement Disorders; Neurons; Psychomotor Performance; Rats; Rats, Long-Evans; Rotenone; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 2011 |
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats.
Topics: Animals; Behavior, Animal; Cell Count; Choline O-Acetyltransferase; Chronic Disease; Corpus Striatum; Disease Models, Animal; Dopamine and cAMP-Regulated Phosphoprotein 32; Drug Administration Schedule; Electron Transport Complex I; Enzyme Inhibitors; Inclusion Bodies; Infusions, Intravenous; Locus Coeruleus; Male; Mesencephalon; Motor Activity; Movement Disorders; NADH, NADPH Oxidoreductases; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroglia; Neurons; Pesticides; Phosphoproteins; Rats; Rats, Inbred Lew; Rotenone; Serotonin; Substantia Nigra; Time; Tyrosine 3-Monooxygenase | 2003 |